awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38212951-D970F9BF-F6EF-4C53-BDCE-42A8389819B5
Q38212951-D970F9BF-F6EF-4C53-BDCE-42A8389819B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38212951-D970F9BF-F6EF-4C53-BDCE-42A8389819B5
Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignancies.
P2860
Q38212951-D970F9BF-F6EF-4C53-BDCE-42A8389819B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38212951-D970F9BF-F6EF-4C53-BDCE-42A8389819B5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
66f20c1c75b53b6c2b754c09181ebe94b2d40c1c
P2860
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.